Mathematical models for different exposure conditions

Dermal Absorption and Toxicity Assessment, Second Edition

Volumn , Issue , 2007, Pages 271-286

  Anissimov, Yuri G ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052827295     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (24)

1. Roberts MS, Anissimov YG. Mathematical models in percutaneous absorption. In:Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology. New York: Marcel Dekker, 2005;1-44.
2. Anissimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics: 1. Effects of flow rate, receptor sampling rate and viable epidermal resistance for a constant donor concentration. J Pharm Sci 1999; 88(11):1201-9.
3. Anissimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 2001; 90(4):504-20.
4. Mueller B, Anissimov YG, Roberts MS. Unexpected clobetasol propionate profile in human stratum corneum after topical application in vitro. Pharm Res 2003; 20(11):1835-7.
5. Anissimov YG, Roberts MS. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics. J Pharm Sci 2004; 93(2):470-87.
6. Roberts MS, Walker M. Water-the most natural penetration enhancer. In:Walters KA, Hadgraft J, eds. Skin Penetration Enhancement. New York: Marcel Dekker, 1993;1-30.
7. Carslaw HS, Jaeger JC. Conduction of Heat in Solids. 2nd ed. Oxford: Clarendon Press, 1959.
8. Kasting GB. Kinetics of finite dose absorption through skin. 1. Vanillylnonanamide. J Pharm Sci 2001; 90(2):202-12.
9. Guy RH, Hadgraft J. A theoretical description relating skin penetration to the thickness of the applied medicament. Int J Pharm 1980; 6(3-4):321-32.
10. Scheuplein RJ, Ross LW. Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 1974; 62(4):353-60.
11. Kasting GB, Miller MA. Kinetics of finite dose absorption through skin. 2. Volatile compounds. J Pharm Sci 2006; 95(2):268-80.
12. Saiyasombati P, Kasting GB. Disposition of benzyl alcohol after topical application to human skin in vitro. J Pharm Sci 2003; 92(10):2128-39.
13. Saiyasombati P, Kasting GB. In vivo evaporation rate of benzyl alcohol from human skin. J Pharm Sci 2004; 93(2):515-20.
14. Nicoli S, Colombo P, Santi P. Release and permeation kinetics of caffeine from bioadhesive transdermal films. AAPS J 2005; 7(1):E218-23.
15. Inoue K, Ogawa K, Okadaa J, Sugibayashic K. Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug. J Control Release 2005; 108(2-3):306-18.
16. Kumprakob U, Kawakami J, Adachi I. Permeation enhancement of ketoprofen using a supersaturated system with antinucleant polymers. Biol Pharm Bull 2005; 28(9):1684-8.
17. Manitz R, Lucht W, Strehmel K, Weiner R, Neubert R. On mathematical modeling of dermal and transdermal drug delivery. J Pharm Sci 1998; 87(7):873-9.
18. Boderke P, Schittkowski K, Wolf M, Merkle HP. Modeling of diffusion and concurrent metabolism in cutaneous tissue. J Theor Biol 2000; 204(3):393-407.
19. Twizell EH, Kubota K. Lag time in the dual sorption model for percutaneous-absorption with finite skin-receptor boundary clearance. Math Biosci 1994; 123(1):1-23.
20. Zatz J. Simulation studies of skin permeation. J Soc Cosmet Chem 1992; 43:37-48.
21. Frasch HF. A random walk model of skin permeation. Risk Anal 2002; 22(2):265-76.
22. Frasch HF, Barbero AM. Steady-state flux and lag time in the stratum corneum lipid pathway: results from finite element models. J Pharm Sci 2003; 92(11):2196-207.
23. McCarley KD, Bunge AL. Physiologically relevant two-compartment pharmaco-kinetic models for skin. J Pharm Sci 2000; 89(9):1212-35.
24. McCarley KD, Bunge AL. Physiologically relevant one-compartment pharmaco-kinetic models for skin. 1. Development of models. J Pharm Sci 1998; 87(4):470-81.